Enthera Pharmaceuticals Raises €28 Million in Series A Financing to Advance Restorative Therapy for Type 1 Diabetes and Inflammatory Bowel Disease

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/32Zcccy
via IFTTT